Study for endometrial cancer progression using transcriptome profiling and AMP-activated protein kinase modulation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028560

Enrollment

Unknown

Registered

2019-12-27

Start date

2019-12-27

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Case series:Nil

Eligibility

Sex/Gender

Female

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients Histologically confirmed endometrial cancer; Age greater than 18 and less than 85, who can understood and signed informed consent.

Exclusion criteria

Exclusion criteria: Patients with other tumors; Medically unfit for surgery.

Design outcomes

Primary

Measure	Time frame
AMPK;	—

Countries

China

Contacts

Public ContactDavid Chan

Gynaecology and Obstetrics Department of Shenzhen Hospital, The University of Hong Kong

dwchan@hku.hk+852 98026120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026